BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 7, 2017
View Archived Issues
ADV-7103 granted E.U. orphan drug designation for distal renal tubulopathy acidosis
Read More
RDD Pharma's RDD-0315 given orphan drug status in E.U.
Read More
FDA grants orphan drug designation to BHV-5000 for Rett syndrome
Read More
Difolta approved in Japan for peripheral T-cell lymphoma
Read More
Trillium Therapeutics identifies EGFR inhibitor
Read More
Hypomorphic CARD11 mutations identified in patients with severe atopic disease
Read More
Novel nucleoside-analogue inhibitor of RNAP shows promising preclinical antibacterial activity
Read More
FDA approves Bristol-Myers Squibb's Orencia in psoriatic arthritis
Read More
Titan Pharmaceuticals enters CRADA to evaluate ProNeura antimalarial implants
Read More
Catalyst Biosciences achieves milestone in ISU ABXIS collaboration
Read More
ProQR Therapeutics receives orphan drug designations in E.U. and U.S. for QRX-411
Read More
Shire submits IND to FDA for SHP-654 as treatment of hemophilia A
Read More
Phase I study finds S-55746 active in acute myeloid leukemia and myelodysplastic syndromes
Read More
Eli Lilly enters partnership with Purdue University
Read More
Shire applies for approval of icatibant in Japan
Read More
First report of PML-RARG gene fusion in an acute promyelocytic leukemia patient
Read More
Anthera opens European screening for phase III study of Sollpura
Read More
Conatus announces Novartis' exclusive license for emricasan is now effective
Read More
Novel methionine aminopeptidase 2 inhibitors discovered by SynDevRx
Read More
Wake Forest, University College Dublin identify new angiotensin (1-7) analogues
Read More
SYGNIS completes Innova acquisition
Read More
Padlock Therapeutics patents protein-arginine deiminase type-4 inhibitors
Read More
University of Queensland, IOCB present novel HGXPRT inhibitors
Read More
Janssen decides not to exercise option to Capricor's CAP-1002 in cardiology
Read More
ProMIS Neurosciences receives matching grant for research on antibodies targeting Abeta oligomers
Read More
Mission Therapeutics discloses novel ubiquitin carboxyl-terminal hydrolase 30 inhibitors
Read More
Puma completes targeted enrollment in phase III trial of neratinib for third-line breast cancer
Read More
Endo agrees to voluntarily remove Opana ER from market
Read More
PET probe [18F]FEONM images Tau in gliomas
Read More
Zoliflodacin to begin phase III development for gonorrhea under new partnership
Read More